期刊文献+

曲安奈德玻璃体腔注射治疗糖尿病性黄斑水肿17例 被引量:1

下载PDF
导出
摘要 糖尿病性黄斑水肿是糖尿病患者视力下降的主要原因之一,在糖尿病史超过20a的患者中约29%会发生黄斑水肿,其中一半以上患者会在2a的随访中出现视力下降[1]。曲安奈德(TA)是一种长效类固醇激素,玻璃体腔注射此种药物可用于治疗多种原因引起的黄斑水肿。近年来,我们采用TA玻璃体腔注射治疗糖尿病性黄斑水肿17例,取得良好疗效。现报告如下。
出处 《山东医药》 CAS 2014年第39期106-107,共2页 Shandong Medical Journal
  • 相关文献

参考文献7

二级参考文献53

  • 1姚毅,王志军,姜荔,杨丙建,王玮,张卯年,林顺潮.玻璃体内注射曲安奈德治疗糖尿病性弥漫性黄斑水肿的初步观察[J].中华眼底病杂志,2005,21(4):217-219. 被引量:36
  • 2刘武,王景昭.玻璃体内注射曲安奈德的问题与并发症[J].中华眼底病杂志,2005,21(4):267-270. 被引量:39
  • 3Pascale Massin,MD. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology 2004,111:218-225
  • 4A P Ciardella,J Klancnik. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates:an optical coherence tomography study.Br J Ophthalmol 2004,88:1131-1136
  • 5Smithen LM,Spaide RF.Photodynamic therapy and intravitreal triamcinolone for a subretinal neovascularization in bilateral idiopathic juxtafoveal telangiectasis.Am J Ophthalmol. 2004 Nov,138(5):884-5
  • 6Rechtman E,Allen VD. Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol.2003 Oct, 136(4):739-41
  • 7Hida T,Chandler D,Arena JE.Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.Am J Ophthalmol. 1986, 101 : 190-195
  • 8Carmen K.M.Chan,MRCP,MRCOphth. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol.2004 Jul, 122(7): 1083
  • 9Ziad F.Bashshur,MD. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion.Arch Ophthalmol.2004, 122: 1137-1140
  • 10T.Micelli Ferrarl,L.Sborgia. Intravitreal triamcinolone acetonide:valuation of retinal thinkness changes measured by optical coherence tomography in diffuse diabetic macular edema.European Journal of Ophthalmology.2004,321-324

共引文献53

同被引文献19

  • 1Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema[ J]. Curr Diab Rep,2012,12(4) :346.
  • 2Goyal S, Lavalley M, Subramanian ML. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema [ J ]. Graefes Arch Clin Exp Ophthalmo1,2011,249 ( 1 ) : 15 - 27.
  • 3Mitchell P, Bandello F, Sehmidt-Erfurth U, et al. The RESTORE study:ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema [ J]. Ophthalmology, 2011, 118(4) :615 -625.
  • 4Boyer DS, Hopkins J J, Sorof J, et al. Anti-vascular endothelial growth factor therapy for diabetic macular edema [ J ]. Ther Adv Endocrinol Metab,2013,4(6) :151 - 169.
  • 5Nguyen QD, Brown DM, Marcus DM, et al. Ranibizumab for diabetic macular edema:results from 2 phase Ⅲ randomized trials:RISE and RIDE [ J]. Ophthalmology ,2012,119 (4) :789 - 801.
  • 6Solaiman KA, Diab MM, Abo-Elenin M. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema[ J ]. Retina ,2010,30 ( 10 ) : 1638 - 1645.
  • 7Kim YT, Kang SW, Kim SJ, et al. Combination of vitrectomy, IVTA, and laser photocoagulation for diabetic macular edema unresponsive to prior treatments ;3 -year results[ J ]. Graefes Arch Clin Exp Oph- thahno1,2012,250 ( 5 ) :679 - 684.
  • 8Zeehmeister-Koss I, Huie M. Vascular endothelial growth factor in- hibitors (anti-VEGF) in the management of diabetic maeular oede- ma:a systematic review[ J]. Br J Ophthalmol,2012,96(2) :167.
  • 9Goyal S, Lavalley M, Subramanian ML. Meta-analysis and review on the effect of bevacizumab in diabetic macular edema [ J ]. Graefes Arch Clin Exp Ophthalmol,2011,249 ( 1 ) : 15 - 27.
  • 10Bakbak B,Ozturk BT, Gonul S, et al. Comparison of the effect of uni- lateral intravitreal bevacizmnab and ranibizumab injection on diabet- ic macular edema of the fellow eye [ J ]. J Ocul Pharmacol Ther, 2013,29(8) :728 -732.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部